🇺🇸 FDA
Patent

US 10428115

Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain

granted A61KA61K38/00A61P

Quick answer

US patent 10428115 (Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P25/04, A61P43/00